Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01014195 : Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors
AgesMin: 8 Years Max: N/A
Inclusion Criteria:

- Enrolled on SJCRH TOTXV ALL protocol

- ? 5 years post diagnosis of ALL

- ? 8.0 years of age at time of follow-up evaluation

Exclusion Criteria:

- History of cranial or total-body radiation therapy

- History of bone marrow transplant

- History of relapse

- History of head injury, neurological condition unrelated to ALL treatment, or
diagnosis of a genetic disorder associated with neurocognitive impairment (e.g. Down
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557